Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1
Aging · 2024
DOI: 10.18632/aging.205750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Xing Ren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Medicine Center, The First Affiliated Hospital of University of South China, Hengyang 421001, Hunan, P.R. China. Hauptthemen laut MEDLINE: Brain Neoplasms, DNA Methylation, Glioma, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Glioma is the most frequently diagnosed primary brain tumor and typically has a poor prognosis because of malignant proliferation and invasion. It is urgent to elucidate the mechanisms driving glioma tumorigenesis and develop novel treatments to address this deadly disease. Here, we first revealed that PDZK1 is expressed at high levels in gliomas. Promoter hypomethylation may cause high expression of PDZK1 in glioma. Knockdown of PDZK1 inhibits glioma cell proliferation and invasion in vitro. Mechanistically, further investigations revealed that the loss of PDZK1 expression by siRNA inhibited the activation of the AKT/mTOR signaling pathway, leading to cell cycle arrest and apoptosis. Clinically, high expression of PDZK1 predicts a poorer prognosis for glioma patients than low expression of PDZK1. Overall, our study revealed that PDZK1 acts as a novel oncogene in glioma by binding to AKT1 and maintaining the activation of the AKT/mTOR signaling pathway. Thus, PDZK1 may be a potential therapeutic target for glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory Medicine Center, The First Affiliated Hospital of University of South China, Hengyang 421001, Hunan, P.R. China.
- Cancer Research Institute, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, P.R. China.
Zitieren
APA
Ren, X., Deng, D., Xiang, S., & Feng, J. (2024). Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1. Aging. https://doi.org/10.18632/aging.205750
Vancouver
Ren X, Deng D, Xiang S, Feng J. Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1. Aging. 2024. doi:10.18632/aging.205750
BibTeX
@article{Ren2024,
author = {Ren, Xing and Deng, Dan and Xiang, Shasha and Feng, Jianbo},
title = {Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205750}
}
EUVIMED